X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10249) 10249
Book Review (3070) 3070
Publication (556) 556
Newsletter (91) 91
Magazine Article (65) 65
Conference Proceeding (44) 44
Web Resource (36) 36
Book / eBook (26) 26
Book Chapter (10) 10
Dissertation (8) 8
Newspaper Article (5) 5
Streaming Video (5) 5
Data Set (2) 2
Presentation (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9244) 9244
humans (9209) 9209
diphosphonates - therapeutic use (7679) 7679
female (5406) 5406
male (3861) 3861
bone density conservation agents - therapeutic use (3354) 3354
middle aged (2990) 2990
aged (2956) 2956
osteoporosis (2610) 2610
bisphosphonates (2543) 2543
zoledronic acid (1897) 1897
diphosphonates - adverse effects (1837) 1837
diphosphonates - administration & dosage (1836) 1836
osteoporosis - drug therapy (1793) 1793
bone neoplasms - secondary (1665) 1665
animals (1653) 1653
adult (1513) 1513
endocrinology & metabolism (1499) 1499
diphosphonates (1494) 1494
imidazoles - therapeutic use (1491) 1491
diphosphonates - pharmacology (1470) 1470
oncology (1451) 1451
treatment outcome (1289) 1289
bone neoplasms - drug therapy (1242) 1242
risk factors (1224) 1224
bone density - drug effects (1180) 1180
aged, 80 and over (1161) 1161
pamidronate (1151) 1151
alendronate (1103) 1103
bone density conservation agents - adverse effects (1086) 1086
abridged index medicus (1046) 1046
bisphosphonate (1037) 1037
orthopedics (1016) 1016
fractures (965) 965
care and treatment (956) 956
drug therapy (953) 953
postmenopausal women (951) 951
medicine & public health (950) 950
bone density (919) 919
bone density conservation agents - administration & dosage (914) 914
osteoporosis, postmenopausal - drug therapy (910) 910
bones (907) 907
cancer (840) 840
therapy (821) 821
rheumatology (816) 816
medicine, general & internal (757) 757
bone (756) 756
double-blind (753) 753
women (750) 750
bone-mineral density (720) 720
research (705) 705
postmenopausal osteoporosis (687) 687
health aspects (680) 680
pharmacology & pharmacy (680) 680
antineoplastic agents - therapeutic use (654) 654
prevention (653) 653
phosphonates (648) 648
breast neoplasms - pathology (644) 644
fractures, bone - prevention & control (639) 639
risk (624) 624
time factors (618) 618
retrospective studies (616) 616
breast neoplasms - drug therapy (609) 609
breast-cancer (599) 599
analysis (592) 592
osteoporosis - prevention & control (589) 589
bone metastases (581) 581
rats (566) 566
imidazoles - administration & dosage (547) 547
dentistry (544) 544
breast cancer (543) 543
metastasis (531) 531
drug administration schedule (520) 520
calcitonin - therapeutic use (515) 515
hypercalcemia - drug therapy (512) 512
administration, oral (507) 507
in-vitro (507) 507
surgery (507) 507
follow-up studies (506) 506
bone density conservation agents - pharmacology (503) 503
mice (493) 493
vitamin d - therapeutic use (484) 484
hypercalcemia - etiology (480) 480
child (476) 476
osteitis deformans - drug therapy (469) 469
imidazoles - pharmacology (468) 468
imidazoles - adverse effects (465) 465
density (457) 457
endocrinology (454) 454
adolescent (441) 441
osteonecrosis - chemically induced (439) 439
denosumab (436) 436
osteonecrosis (436) 436
infusions, intravenous (433) 433
multiple-myeloma (419) 419
randomized controlled trials as topic (419) 419
clinical trials as topic (412) 412
etidronic acid - therapeutic use (412) 412
bone and bones - drug effects (408) 408
bone resorption - drug therapy (408) 408
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (35) 35
Gerstein Science - Stacks (16) 16
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Dentistry (Harry R Abbott) - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9210) 9210
Japanese (353) 353
German (261) 261
French (254) 254
Spanish (84) 84
Italian (50) 50
Chinese (41) 41
Russian (36) 36
Danish (27) 27
Dutch (27) 27
Polish (24) 24
Hungarian (21) 21
Czech (15) 15
Finnish (15) 15
Croatian (11) 11
Hebrew (10) 10
Swedish (10) 10
Norwegian (8) 8
Portuguese (7) 7
Ukrainian (6) 6
Slovak (4) 4
Lithuanian (2) 2
Serbian (2) 2
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2014, Pharmacology-research, safety testing, and regulation, ISBN 9781633215528
Web Resource
The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 7, pp. 679 - 691
This large trial tested the effect of adding zoledronic acid to adjuvant endocrine treatment (goserelin plus tamoxifen or anastrozole) in premenopausal women... 
RECEIVING ADJUVANT LETROZOLE | MULTIPLE-MYELOMA | OVARIAN ABLATION | BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | MEDICINE, GENERAL & INTERNAL | BONE LOSS | SOLID TUMORS | TAMOXIFEN | DELTA-T-CELLS | POSTMENOPAUSAL WOMEN | AUSTRIAN BREAST | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 7, pp. 631 - 641
Journal Article
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 2013, Volume 24, Issue 2, pp. 398 - 405
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9768, pp. 813 - 822
Journal Article
Journal of Oral and Maxillofacial Surgery, ISSN 0278-2391, 2013, Volume 71, Issue 9, pp. 1532 - 1540
Purpose To investigate the efficacy and safety of zoledronic acid (ZA) combined with targeted therapy (TT). Materials and Methods A retrospective study was... 
Surgery | SURVIVAL | PROSTATE | ADHESION | BISPHOSPHONATES | CANCER-PATIENTS | NECROSIS | DENTISTRY, ORAL SURGERY & MEDICINE | SKELETAL-RELATED EVENTS | SUNITINIB | BREAST | PROGRESSION | Niacinamide - analogs & derivatives | Follow-Up Studies | Humans | Middle Aged | Interleukin-2 - therapeutic use | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Bevacizumab | Angiogenesis Inhibitors - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Diphosphonates - adverse effects | Everolimus | Molecular Targeted Therapy - methods | Radiography, Panoramic | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Bone Density Conservation Agents - adverse effects | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Fractures, Spontaneous - etiology | Survival Rate | Spinal Cord Compression - etiology | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Carcinoma, Renal Cell - secondary | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Cohort Studies | Care and treatment | Trade and professional associations | Metastasis | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article